Other Data

Other Data


Conference Call Transcripts

Q1 FY2017 Conference Call Transcript

Postal Ballot Results 13.3.2017

AGM Date, Book Closure for Dividend, AGM, Record Date, Cut off Date

Outcome of Board meeting 31.8.2017

Notice of AGM

Q4 and Full Year FY2016 Conference Call Transcript

Concall to discuss the Sale of Certain Products in SpecChem Division

Vivimed_Q1_FY2015
Conference_Call_Transcript

Vivimed_Q2_FY2015
Conference_Call_Transcript

Vivimed_Q3_FY2015
Conference_Call_Transcript

Q4 and Full Year FY2014 Conference Call Transcript

Q3 FY2014 Conference Call Transcript

Q2 FY2014 Conference Call Transcript

Q1 FY2014 Conference Call Transcript

Actavis Acquisition Call Transcript

Q4 FY2013 Earnings Call Transcript

Q4 and Full Year FY2013 Conference Call Invite

Q3 FY2013 Earnings Call Transcript

Q2 FY2013 Earnings Call Transcript

Q1 FY2013 Earnings Call Transcript


Corporate Policies

Corporate Governance

Code of Conduct

Code of Conduct for Directors and Management

Terms and Conditions of Appointment of Independent Directors

Criteria of Making Payments to Non-Executive Directors

Key Managerial Person

Familarisation Programme for Independent Directors

Policy on Determination of Materiality

Policy of Related Party

Insider Trading Policy (UPSI)

Whistle Blowers Policy

Policy on Material Subsidiary

Archival Policy

Risk Policy

CSR Policy


IEPF


Unclaimed Dividend Transferred to IEPF  2007-08

Unclaimed Dividend Transferred to IEPF  2008-09

Unclaimed Dividend Transferred to IEPF  2009-10

Investor Presentation

Investor Presentation May 2015


Postal Ballot Notice

Postal Ballot Notice

Postal Ballot Notice


Press Releases

ESOP Allotment

Results and dividend- MAY 2017

Re Constitution of Audit Committee

Announces Sale of Certain Products of its Subsidiary (Jul-16)

Outcome of the Board Meeting

CCI Approval (Dec-15)

Sale of Certain Products in SpecChem Division (Sep-15)

Satisfactory Outcome of USFDA Inspection (Sep-15)

Q1 FY2014 Earnings Press Release

Acquires a US FDA approved formulation manufacturing facility

Clarification

Receives the PIC/S GMP approval for one of its pharmaceuticals manufacturing facilities in Hyderabad

Share Price Clarification

Clarification on allotment of Equity Shares

Allotment of Equity Shares

08-Mar-2013: Care Ratings


Research Coverage

Reliance – Feb 2013

Sumedha – Dec 2012

Fullerton – Nov 2012

MSFL – Aug 2012

Sumedha – Jun 2012

Reliance – Jun 2012

Reliance – Apr 2012


Research Reports

Anand Rathi April 2015


Scheme of Amalgamation

Vivimed Letter to BSE (Sept 2017)

Vivimed Letter to NSE (Sept 2017)

Observation Letter Regarding Scheme of Amalgamation – BSE (Apr 2016)

Observation Letter Regarding Scheme of Amalgamation – NSE (Apr 2016)

Scheme of Amalgamation – BSE (Aug 2014)

Scheme of Amalgamation – NSE (Aug 2014)

Creative Health Memorandum and Article of Association

Klar Sehen Memorandum and Article of Association

Octtantis Memorandum and Article of Association

Vivimed Memorandum and Article of Association

Alathur Change of Name (Aug 2013)

Alathur FY2012 Financial Results

Alathur FY2014 Financial Results

Creative Health FY2014 Annual Report

Creative Health FY2013 Annual Report

Creative Health FY2012 Annual Report

Klar Shen FY2014 Annual Report

Klar Sehen FY2014 Financial Results

Klar Shen FY2013 Annual Report

Klar Shen FY2012 Annual Report

Octtantis FY2014 Financial Results

Octtantis FY2013 Financial Results

Octtantis FY2012 Financial Results